Biomx Inc
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic f… Read more
Biomx Inc (PHGE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.685x
Based on the latest financial reports, Biomx Inc (PHGE) has a cash flow conversion efficiency ratio of -0.685x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.18 Million) by net assets ($10.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biomx Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Biomx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biomx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biomx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KonaTel Inc
OTCQB:KTEL
|
-2.579x |
|
AdCapital AG
F:ADC
|
N/A |
|
Intercontinental International Real Estate Investment Company
AT:INTERCO
|
0.015x |
|
ZoomerMedia Limited
PINK:ZUMRF
|
0.014x |
|
Motio Ltd
AU:MXO
|
0.190x |
|
Sego Resources Inc
V:SGZ
|
-0.015x |
|
Temas Resources Corp
OTCQB:TMASF
|
-0.116x |
|
Italtile Ltd
JSE:ITE
|
0.137x |
Annual Cash Flow Conversion Efficiency for Biomx Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Biomx Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $24.15 Million | $-36.98 Million | -1.531x | +77.83% |
| 2023-12-31 | $3.08 Million | $-21.29 Million | -6.909x | -399.64% |
| 2022-12-31 | $21.04 Million | $-29.09 Million | -1.383x | -138.38% |
| 2021-12-31 | $47.53 Million | $-27.57 Million | -0.580x | -36.36% |
| 2020-12-31 | $57.47 Million | $-24.45 Million | -0.425x | -104.40% |
| 2019-12-31 | $84.46 Million | $-17.58 Million | -0.208x | +21.19% |
| 2018-12-31 | $42.80 Million | $-11.30 Million | -0.264x | +25.73% |
| 2017-12-31 | $11.53 Million | $-4.10 Million | -0.356x | -- |